The objective of this study was to describe the longitudinal cognitive outcome in Alzheimer's disease (AD) and analyze factors that affect the outcome, including the impact of different cholinesterase inhibitors (ChEI). This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.